| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/17/2013 | US8535890 Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies |
| 09/17/2013 | US8535879 Structuring hydrogels |
| 09/17/2013 | US8535690 Tumor specific animal proteins |
| 09/17/2013 | US8535673 A humanized antibody that specifically binds an epitope contained within positions 13-28 of A beta; used for treating Alzheimer's disease in both asymptomatic patients and those currently showing symptoms of disease. |
| 09/17/2013 | US8535670 Method of treating colorectal cancer tumor |
| 09/17/2013 | US8535667 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 09/17/2013 | US8535665 Process for identification of molecular mimicry and the uses thereof |
| 09/17/2013 | US8535635 Method of manufacturing carbon cylindrical structures and biopolymer detection device |
| 09/17/2013 | US8535609 Test element analysis system |
| 09/17/2013 | US8535608 Analytical system and method for its operation |
| 09/17/2013 | US8535607 Sample analyzer |
| 09/17/2013 | US8535541 Method for separating immunomagnetic bead labeled particulates |
| 09/17/2013 | US8535511 Methods for electrochemical analysis using matrix compositions with alkylphenazine quaternary salt and a nitrosoaniline |
| 09/17/2013 | US8535497 Method of measuring blood component, sensor used in the method, and measuring device |
| 09/17/2013 | US8534114 Sand detector calibration |
| 09/17/2013 | CA2752321C A milk conveyer device |
| 09/17/2013 | CA2700608C Method for producing juice having pre-selected taste-related properties and characteristics |
| 09/17/2013 | CA2700086C Antigen detection kit and method |
| 09/17/2013 | CA2563887C Mite allergen zen 1 |
| 09/17/2013 | CA2546794C Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 09/17/2013 | CA2545006C Biosensors for detecting macromolecules and other analytes |
| 09/17/2013 | CA2541059C Fluorescent probes for use in protein kinase inhibitor binding assay |
| 09/17/2013 | CA2533789C Epha2 t-cell epitope agonists and uses therefor |
| 09/17/2013 | CA2532394C Rg1 antibodies and uses thereof |
| 09/17/2013 | CA2516519C Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/17/2013 | CA2513646C Target activated microtransfer |
| 09/17/2013 | CA2347067C Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer |
| 09/17/2013 | CA2285701C .beta.-catenin, tcf-4, and apc interact to prevent cancer |
| 09/12/2013 | WO2013134743A1 Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof |
| 09/12/2013 | WO2013134689A1 A biochemical sensor for quantitative simultaneous multi-species bacteria detection in situ |
| 09/12/2013 | WO2013134676A1 Anaplasma family members cause a number of blood-borne diseases |
| 09/12/2013 | WO2013134658A1 Methods of identifying gene isoforms for anti-cancer treatments |
| 09/12/2013 | WO2013134649A1 Biomarkers for cancer stem cells and related methods of use |
| 09/12/2013 | WO2013134647A1 Methods and kits for analyzing biomarkers in a signal transduction pathway |
| 09/12/2013 | WO2013134583A1 Device and method for controlling the temperature in a moving fluid in a laboratory sample processing system |
| 09/12/2013 | WO2013134582A1 Analyte sensing device |
| 09/12/2013 | WO2013134546A1 Methods and materials for treating cancer |
| 09/12/2013 | WO2013134538A1 Portable device and method for field testing proppant |
| 09/12/2013 | WO2013134503A2 Methods And Compositions For Detecting Multiple Analytes With A Single Signal |
| 09/12/2013 | WO2013134499A1 Anastasis biosensor |
| 09/12/2013 | WO2013134431A1 Biomarkers for systemic lupus erythematosus |
| 09/12/2013 | WO2013134325A1 Transformation system for optimization of nutritional substances at consumption |
| 09/12/2013 | WO2013134315A1 Compositions and methods for diagnosis and treatment of pervasive developmental disorder |
| 09/12/2013 | WO2013134224A1 Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome |
| 09/12/2013 | WO2013134035A1 Organic colloid-stabilized emulsion for controlling pesticide spray drift |
| 09/12/2013 | WO2013133917A1 Sandwich assay for immunosuppressant drugs |
| 09/12/2013 | WO2013133904A2 Detection of rate changes in systematic oscillations of metabolic pathways by monitoring isotope ratios |
| 09/12/2013 | WO2013133876A1 Biomarkers for prediction of response to parp inhibition in breast cancer |
| 09/12/2013 | WO2013133872A1 Detection and measurement of volatile organic compounds |
| 09/12/2013 | WO2013133700A1 Method for removing a high definition nanostructure, a partly freestanding layer, a sensor comprising said layer and a method using said sensor |
| 09/12/2013 | WO2013133675A1 Multiple biomarker sets for breast cancer diagnosis, detection method therefor, and breast cancer diagnostic kit comprising antibody against same |
| 09/12/2013 | WO2013133590A1 Petroleum-like substance detection device and method |
| 09/12/2013 | WO2013133561A1 Detection of nucleotide variation on target nucleic acid sequence by pto cleavage and extension assay |
| 09/12/2013 | WO2013133472A1 Activating transcription factor 3 (atf3) for toxicity prediction and as therapeutic target |
| 09/12/2013 | WO2013133459A1 Reagent composition for biosensors and biosensor comprising reagent layer formed of the same |
| 09/12/2013 | WO2013133458A1 Microfluidic system |
| 09/12/2013 | WO2013133402A1 Method for detecting single nucleotide polymorphism in nucleic acid |
| 09/12/2013 | WO2013133351A1 Novel fgfr3 fusion product |
| 09/12/2013 | WO2013133297A1 Method for stimulating t cell and use thereof |
| 09/12/2013 | WO2013133283A1 Determination method, determination device, determination system, and program |
| 09/12/2013 | WO2013133243A1 Juvenile hormone epoxidase gene and use thereof |
| 09/12/2013 | WO2013133220A1 Cancer malignancy testing method, pluripotent tumorigenic cells, and preparation method therefor |
| 09/12/2013 | WO2013132998A1 Image processing device, microscope system, and image processing method |
| 09/12/2013 | WO2013132630A1 Method and device for detecting microorganisms in liquid |
| 09/12/2013 | WO2013132622A1 Method for distinguishing tobacco raw-material categories |
| 09/12/2013 | WO2013132502A1 Method and kit for the detection of hepatitis-specific antibodies |
| 09/12/2013 | WO2013132496A1 Methods and kits for the detection of viral infections |
| 09/12/2013 | WO2013132455A1 Process and device for the determination of alterations in neuronal connectivity and/or morphology |
| 09/12/2013 | WO2013132440A1 Tumor biomarkers for pancreatic cancer |
| 09/12/2013 | WO2013132245A1 Method for characterising plasma cell associated diseases |
| 09/12/2013 | WO2013132206A1 Biological fluid monitoring device |
| 09/12/2013 | WO2013132198A1 Interfering peptides and method for detecting micro-organisms |
| 09/12/2013 | WO2013132107A1 Chimeric virus -like particles (vlp) containing functional hmpv proteins |
| 09/12/2013 | WO2013132090A1 A method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject |
| 09/12/2013 | WO2013132089A2 A method for predicting the risk of getting cancer or diagnosing cancer in a female subject |
| 09/12/2013 | WO2013132088A1 A method for predicting the risk of getting a cardiovascular event in a female subject |
| 09/12/2013 | WO2013132085A1 A portable sampling device and method for detection of biomarkers in exhaled breath |
| 09/12/2013 | WO2013132075A1 Method |
| 09/12/2013 | WO2013132040A2 In vitro potency assay for protein-based meningococcal vaccines |
| 09/12/2013 | WO2013132036A1 Optimal gonadotropin dosage |
| 09/12/2013 | WO2013132000A1 Multiplexed chromatography-immunoassay method for the characterization of circulating immune complexes |
| 09/12/2013 | WO2013131999A1 Method and device for evaluating a wooden board |
| 09/12/2013 | WO2013131991A1 Means and methods for determining neurotoxin activity based on a modified luciferase |
| 09/12/2013 | WO2013131955A1 Method and device for detecting analytes |
| 09/12/2013 | WO2013131934A1 A cartridge |
| 09/12/2013 | WO2013131933A1 In vitro method for determining disease outcome in pulmonary carcinoids |
| 09/12/2013 | WO2013131841A1 Method of determining teratogenic risk |
| 09/12/2013 | WO2013131785A1 Method for the evaluation of the colloidal stability of liquid biopolymer solutions |
| 09/12/2013 | WO2013131733A1 Method for performing immunoassays under weightless conditions |
| 09/12/2013 | WO2013131697A1 Probe for continuous measurement of the oxygen saturation in metal melts |
| 09/12/2013 | WO2013131621A1 Prediction of outcome in patients with chronic obstructive pulmonary disease |
| 09/12/2013 | WO2013131411A1 Micro-devices for improved disease detection |
| 09/12/2013 | WO2013131198A1 Measuring head for testing yarn |
| 09/12/2013 | WO2013131192A1 Placental stem cells, methods for isolating same and use thereof |
| 09/12/2013 | WO2013106851A3 Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes |
| 09/12/2013 | WO2013087654A3 Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation |
| 09/12/2013 | WO2013070796A3 Propeptide-luciferase fusion proteins and methods of use thereof |
| 09/12/2013 | WO2013067489A9 Nucleic acid-based linkers for detecting and measuring interactions |
| 09/12/2013 | WO2013052933A3 Myosin binding protein- c for use in methods relating to diastolic heart failure |
| 09/12/2013 | WO2012078618A3 Predicting and treating diabetic complications |